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Abstract
Rationale Dopamine (DA) plays a key role in reward-
seeking behaviours. Accumulating evidence from animal
and human studies suggests that human sexual reward
learning may also depend on DA transmission. However,
research on the role of DA in human sexual reward learn-
ing is completely lacking.
Objectives To investigate whether DA antagonism attenuates
classical conditioning of sexual response in humans.
Methods Healthy women were randomly allocated to one of
two treatment conditions: haloperidol (n= 29) or placebo
(n=29). A differential conditioning paradigm was applied
with genital vibrostimulation as unconditional stimulus (US)
and neutral pictures as conditional stimuli (CSs). Genital
arousal was assessed, and ratings of affective value and sub-
jective sexual arousal were obtained.
Results Haloperidol administration affected unconditional
genital responding. However, no significant effects of medi-
cation were found for conditioned responding.
Conclusions No firm conclusions can be drawn about wheth-
er female sexual reward learning implicates DA transmission
since the results do not lend themselves to unambiguous
interpretation.
Keywords Sexual conditioning . Dopamine antagonist .
Sexual reward learning . Sexual response . Haloperidol
Introduction
The dopaminergic reward system has been implicated to be
involved in the acquisition and expression of learned appeti-
tive behaviours (Dominguez and Hull 2005; Fields et al. 2007;
Richard et al. 2013; Schultz 2002), and abnormality in this
system has been shown to play a role in the aetiology and
pathophysiology of various disorders, including substance
use disorders and (behavioural) addictions (De Jong et al.
2015; Dunlop and Nemeroff 2007; Root et al. 2015). Many
theories of human sexual behaviour assume that sexual stimuli
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Pavlovian) learning processes (Brom et al. 2014a; Pfaus et al.
2001; Toates 2009). Therefore, the onset of disorders in sexual
motivation such as female sexual interest/arousal disorder
(Diagnostic and Statistical Manual of Mental Disorders
[DSM-5] American Psychiatric Association 2013) or hyper-
sexuality may be explained from a classical conditioning and
incentive motivation perspective (Brom et al. 2014a; Laan and
Both 2008; Singer and Toates 1987). However, despite the
substantial amount of research that suggests that mesolimbic
dopamine (DA) neurotransmission plays an important role in
aversive learning (Zweifel et al. 2011), as well as reward learn-
ing (Berridge 2007; Berridge and Robinson 1998, 2003; Brom
et al. 2014a; Di Chiara 1995; Kringelbach and Berridge 2009),
to date, no human research has been conducted on the role of
DA in human sexual reward learning, while facilitation as well
as impairment thereof is relevant in the context of treatment of
sexual motivation disorders.
Stimuli that can promote motivation are called incentive
stimuli (Bindra 1974; Singer and Toates 1987). Their motiva-
tional valence can be unconditional or conditional as a result
of associative leaning (Di Chiara 1995). A previously neutral
stimulus (NS) that predicts reward (i.e. unconditional stimulus
(US)) can acquire motivational properties, becoming an attrac-
tive and desirable incentive stimulus (i.e. conditional stimulus
(CS)). As a result of repeated association of the NS with the
US, the NSmay eventually trigger similar responses as the US
(i.e. the conditioned response (CR)) (Pavlov 1927). However,
it is important to mention that the NS does not always have to
trigger the exact same response as the US does (Fanselow
et al. 1994), and therefore, the CR may not always equal the
unconditioned response (UR). Subsequent repeated presenta-
tions of a CSwithout the USwill result in a loss of conditioned
responding (i.e. extinction), as the CS no longer predicts the
appetitive US (Delamater 2004). Several studies have demon-
strated conditioned sexual arousal responses in animals and
humans (Both et al. 2011; Brom et al. 2014a, b, c; Pfaus et al.
2001).
Rewards like food, drugs and sex have the ability to stim-
ulate mesolimbic DA neurons projecting from the ventral teg-
mental area (VTA) to the nucleus accumbens (NAc), and in-
creased extracellular concentrations of mesolimbic DA are
implicated in responding for conditioned reinforcers
(Berridge 2007; Georgiadis and Kringelbach 2012; Pierce
and Kumaresan 2006; Richard et al. 2013). A recent function-
al MRI (fMRI) study (Oei et al. 2012) provides compelling
evidence for a mediating role of DA in processing of subcon-
scious perceived sexual stimuli. In healthy young men, levo-
dopa (a DA agonist) enhanced the activation in the NAc and
dorsal anterior cingulate cortex in response to subliminal
sexual stimuli, whereas haloperidol decreased activations in
those areas. Both et al. (2005) demonstrated a relation be-
tween dopaminergic activity and motor preparation in re-
sponse to sexual stimuli. Moreover, substantial evidence
suggests that mesolimbic DA plays a critical role in the incen-
tive and acquisition aspect of reward (Berridge 2007; Schultz
2002; Wise 2002). The incentive salience theory describes
mechanisms by which DA transmission in the NAc trans-
forms the neural representations of conditioned stimuli,
converting an event or environmental stimulus from a neutral
representation into an attractive and ‘wanted’ incentive
(Berridge 2007; Flagel et al. 2010). Research has shown that
DA agonists or DA uptake inhibitors, such as D-amphetamine
or methylphenidate, increase conditioned responding in rats
(Beninger and Phillips 1980; Cummins et al. 2014; Taylor and
Robbins 1984) and humans (Kassubek et al. 2011), whereas
DA antagonists decrease conditioned responding in rats
(Banasikowski et al. 2010; Ranaldi and Beninger 1993;
Wolterink et al. 1993). For instance, in rats, haloperidol selec-
tively attenuates conditioned cue-induced sexual motivation
(Coria-Avila et al. 2008; López and Ettenberg 2002). In
humans, dopaminergic influences on reward learning were
observed in studies by Pessiglione et al. (2006) and Pleger
et al. (2009), in which participants were administered a single
dose of haloperidol or levodopa preceding an instrumental
learning task and a reward decision-making task respectively.
Haloperidol attenuated, and levodopa enhanced learning
effects. However, in contrast, Pizzagalli et al. (2008) and
Santesso et al. (2011) demonstrated that a single dose of the
DA agonist pramipexole impaired the acquisition of reward-
related behaviour in healthy participants. This blunted reward
learning was explained by the assumption that low doses of
pramipexole may influence reward via a paradoxical effect
related to activation of the presynaptic DA autoreceptor,
resulting in a blockade of phasic DA release and a blunted
response to rewarding stimuli (Riba et al. 2008). As the mixed
results make clear, the role of DA signalling in incentive learn-
ing in humans remains largely unknown. Therefore, in the
present study, making use of a double-blind, placebo-
controlled design, it was investigated whether DA antagonism
attenuates classical conditioning of sexual response in women.
It was expected that administration of the DA antagonist hal-




A total of 58 healthy sexually active women from the general
population were recruited by means of advertisements and
were randomly allocated to two treatment conditions: placebo
n=29 and haloperidol n=29. The inclusion criteria were age
between 18 and 45 years and a heterosexual orientation; no
pregnancy or breastfeeding; no current (or history of) sexual
complaints as determined by the Female Sexual Function
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Index (FSFI; Rosen et al. 2000; Ter Kuile et al. 2006) or
psychiatric problems as determined by the MINI
International Neuropsychiatric Interview (MINI; Sheehan
et al. 1998); no history of sexual abuse; no medical illness
(or medical history) indicating a risk in using haloperidol
(e.g. cardiac illness, depression, thyroid disorders, glaucoma);
no use of medication affecting sexual response and no current
or recent use (<12 weeks before participation) of psycho-
pharmacological medication, psychotropic drugs or medica-
tion that might interfere with haloperidol (e.g. cannabis or
cocaine). Participants were paid €50 for their participation,
and written informed consent was obtained from all partici-
pants. The study was approved by the Medical Ethics
Committee and carried out according to the standards of the
Declaration of Helsinki (Declaration of Helsinki 2000).
Medication
Participants received a single dose of haloperidol (3 mg, the
mean time of maximal plasma levels (Tmax) = 3–6 h, half-
time = 14–36 h; Liem-Moolenaar et al. 2010) or placebo
(microcristalline cellulose), hidden in identical gelatine cap-
sules to ensure that both participants and experimenters could
not identify the drugs. Following dosing, participants rested
for 3 h to allow drug absorption. This timing was based upon a
studies in healthy volunteers that showed 60–70 % D2 recep-
tor occupancy and maximal plasma concentrations 3 h after
haloperidol administration (Darby et al. 1995; Nordstrom
et al. 1992) and on research that showed haloperidol effects
1 h after dosing on cognitive tests making use of a reliable
central nervous system (CNS) measurement battery (Liem-
Moolenaar et al. 2010). Moreover, previous studies from our
lab (Oei et al. 2012) demonstrated decreased activations in
brain reward structures 4 h after oral ingestion of 3 mg
haloperidol.
Conditioning procedure
The experimental design involved differential conditioning
with one stimulus (the CS+) being followed by genital
vibrostimulation (US) during the acquisition phase, whereas
the other stimulus (CS−) was never followed by genital
vibrostimulation. For a schematic overview of the procedure,
see Fig. 1. In the preconditioning phase, participants saw four
non-reinforced presentations of the CS+ and four presenta-
tions of the CS−, for 11 s each. Subsequently, in the acquisi-
tion phase, the CS+ and CS−were presented eight times each,
and after 10 s, the CS+ was always followed by the US for 2 s.
In the extinction phase, the CS+ and CS− were presented six
times each, and now, the CS+ was no longer followed by the
US. All phases were presented without interruption. There
were two random CS orders for each phase (that was
counterbalanced across participants), with the restriction of
only two successive presentations of each CS. During the
whole procedure, inter-trial intervals (ITIs) were 20, 25 or
30 s. The order of the length of the ITI was random, with
the restriction of only two similar successive lengths.
Stimulus materials
Two similar neutral pictures of pictorial male faces (Both et al.
2011; Brom et al. 2014b) served as CSs. The CSs were shown
in the middle of a computer monitor, approximately 1.5 m in
front of the participant. The size of the presented pictures was
14×21 cm. Assignment of the pictures as CS+ and CS− was
counterbalanced across participants and conditions. A com-
puter program timed the administration of the CS and US
stimuli.
Genital vibrostimulation (US)
A small hands-off vibrator (2-cm diameter) (Both et al. 2008,
2011; Brom et al. 2014b) was placed on the clitoris using a
lycra panties. All participants were instructed to position the
vibrator as most sexually stimulating.
Genital arousal
Vaginal photoplethysmography assessed vaginal pulse ampli-
tude (VPA) (Laan and Everaerd 1995; Laan et al. 1995). VPA
is a reliable measure specific to sexual arousal (Laan et al.
1995; Suschinsky et al. 2009). The photoplethysmograph is
a menstrual tampon-sized device containing an orange-red
light source and a photocell. The light source illuminates the
capillary bed of the vaginal wall and the blood circulation
within it. Depth of the probe and orientation of the light emit-
ting diode were controlled by a device (a 6×2-cm plate) at-
tached to the cable within 5 cm of the light sensor. The
photoplethysmograph was disinfected at the medical centre
by means of a plasma sterilization procedure between uses.
Plasma sterilization is a highly effective method for the com-
plete removal of all organic (and certain inorganic) material.
Genital response was measured continuously during resting
baseline, preconditioning, acquisition and extinction phases.
Subjective ratings
Ratings of affective value and sexual arousal were collected
during the preconditioning and extinction phases. Participants
were first asked to rate, after each CS presentation, the affec-
tive value of the CSs by answering the question ‘What kind of
feeling does this picture evoke in you?’ The question could be
answered on a 7-point Likert scale on a keyboard that varied
from very negative to very positive. Then, subjective sexual
arousal was rated by answering the question ‘How sexually
arousing is this picture to you?’ The question could be
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answered on a 7-point scale that varied from not sexually
arousing at all to very sexually arousing. The questions were
presented at the monitor 1 s following the end of picture
presentation.
The Female Sexual Function Index
Women’s sexual functioning was assessed by the FSFI (Rosen
et al. 2000; Ter Kuile et al. 2006), consisting of six subscales:
desire (two items; range 1–5), arousal (four items; range 0–5),
lubrication (four items; range 0–5), orgasm (three items; range
0–5), satisfaction (three items; range 0–5) and pain (three
items; range 0–5). A higher score indicates better sexual func-
tioning. The FSFI has good internal reliability and is able to
differentiate between clinical samples and functional controls
(Rosen et al. 2000; Ter Kuile et al. 2006).
Procedure
A female who was a trained experimenter tested each
participant individually. Women were not tested during
menstruation. Before entering the experimental session,
participants were instructed about the genital device and
vibrostimulation and informed consent was obtained.
Participants received a capsule (placebo or haloperidol)
3 h before the experimental conditioning procedure to
ensure the occurrence of peak plasma concentrations of
the drugs during the experiment (Darby et al. 1995;
Liem-Moolenaar et al. 2010; Nordstrom et al. 1992).
After ingestion of the capsule, participants filled out ques-
tionnaires (e.g. FSFI). They were allowed to read during
the waiting period. Exactly 3 h after ingesting the capsule,
the experimental procedure started. Participants privately
inserted the vaginal device and placed the vibrator.
Further instructions were given through instructions on
screen. Three presentations of vibrostimulation of 2 s each
allowed the participant to position the vibrator in the way
it was most sexually arousing. It was emphasized that
after final placement, the position of the vibrator should
not be changed during the experiment. A 5-min resting
period followed, during which a neutral film was played
and baseline measurements of genital response were col-
lected during the last 2 min. Subsequently, the condition-
ing procedure followed. After the experiment finished,
participants themselves removed the genital devices pri-
vately. Next, a debriefing interview was administered in
which participants were asked about their sentiments with
regard to the experimental procedure, the use of the gen-
i ta l device and thei r eva lua t ion of the geni ta l
vibrostimulation. Finally, participants were thanked and
paid for their participation and advised to refrain from
alcohol and drug use the next 24 h.
Data reduction, scoring and analysis
A software program (VSRRP98) was used to analyze the
genital data. After artefact removal, mean VPA level dur-
ing the 2-min resting baseline period was calculated.
Genital responses to the CSs were scored in three latency
windows: during 4–8, 9–12 and 13–16 s following CS
onset, respectively first interval response (FIR), second
interval response (SIR) and third interval response
(TIR). These time intervals are based on previous data
(Both et al. 2011; Brom et al. 2014b) showing that vagi-
nal blood engorgement is a relatively slow physiological
response. For FIR, SIR and TIR, change scores were cal-
culated for each CS presentation by subtracting mean gen-
ital resting baseline from genital response following CS
presentation. For genital responses and subjective ratings,
effects were tested with repeated measures univariate
analysis of variance procedures (general linear model in
SPSS), with stimulus and trial as within-subject factors
and cond i t i on as be tween - sub je c t f a c to r. The
Greenhouse–Geisser correction was applied to adjust for
violation of the sphericity assumption in testing repeated
measures effects. The preconditioning, acquisition and ex-
tinction phases were analyzed separately. Effect sizes are
reported as proportion of partial variance (ηp
2) (Cohen
1988). In addition, the strength of the unconditioned and
conditioned genital response was determined. The
Fig. 1 Schematic representation
of the conditioning procedure and
extinction phase, with on the right
the used stimuli that served as
CSs
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magnitude of the UR was determined by calculating the
percentage of preconditioning VPA score (mean VPA in
response to the CS+ plus vibration during the acquisition
phase /mean VPA in response to the CS+ during the pre-
conditioning phase × 100). The magnitude of the CR was
determined by calculating the percentage of the mean
VPA in response to vibration (VPA in response to the
CS+ during the first extinction trial / mean VPA in re-
sponse to the CS+ plus vibration during the acquisition
phase × 100).
Results
The participants in the two conditions appeared to differ in
age and in prior experience with genital vibrostimulation,
see Table 1 Participant characteristics. Genital data from
one participant (from the haloperidol condition) were
discarded as outlier since measures from this participant
were under 3 SD from the mean (although inclusion of this
participant did not change results). There was no relation
between the medication the participants had received and
the percentage that correctly guessed what they had re-
ceived (Pearson chi-squared = 2.75, p = 0.25), suggesting
that blinding was successful. Most participants reported no
side effects (n= 37). Among the 21 participants who did
report side effects, the most commonly reported ones were
fatigue, sleepiness and dizziness. Participants in the halo-
peridol condition reported more side effects as compared to
participants in the placebo condition (Fisher’s exact




Analyses were conducted to verify equal levels of VPA in
response to the CS+ and CS− during the preconditioning
phase. For all latency windows (FIR, SIR and TIR), no differ-
ence in VPA following presentation of the CS+ and CS− was
found, all ps>0.23. On TIR, a significant stimulus × condition
interaction effect was found, F(1, 55)=6.74, p=0.01, ηp
2=.11.
As can be seen in Fig. 2, participants in the haloperidol con-
dition demonstrated higher VPA responses towards the CS−,
whereas women in the placebo condition had higher VPA in
response to the CS+ in the preconditioning phase.
Acquisition phase
VPA in response to the vibrostimulation during the acquisition
phase was determined in order to verify whether the
vibrostimulation served as a sexually arousing US. Genital
responses in the second and third latency windows (SIR,
TIR) were considered as unconditioned responses. Figure 2
summarizes VPA TIR to CS+ and CS− across trials for both
conditions separately. In line with previous studies (Both et al.
2008, 2011; Brom et al. 2014b), the 2 (stimulus) × 8 (trial) × 2
(condition) mixed factors ANOVA of VPA revealed only a
significant main effect of stimulus on TIR, FIR p= 0.28,
SIR, p=0.11, TIR, F(1, 54) =5.65, p=0.02, ηp
2=.10, meaning
the CS+ plus vibrostimulation elicited higher levels of VPA.
On FIR and SIR, there were no significant stimulus × condi-
tion interaction effects, FIR p=0.51, SIR p=0.38, or stimulus
× trial × condition interaction effects, FIR p= 0.86; SIR
Table 1 Participant
characteristics Placebo (n= 29) Haloperidol (n= 29)
M SD M SD p
Age (years) 22.24 3.14 20.31 1.71 <0.01*
Sexual functioning (FSFI score) 28.63 5.97 28.81 5.63 0.90
Prior experience vibrostimulation 3.00 1.28 2.24 1.12 0.02*
Pleasantness US 2.24 0.64 2.28 0.65 0.84
US perceived as sexually arousing 2.62 0.78 2.48 0.63 0.46
Declared sexual arousal 2.03 0.73 2.14 0.69 0.58
Frequency Frequency
Use of contraceptives No use or non-hormonal 5 3 0.72
Hormonal 24 26
Descriptive subject variables for each condition.Women’s sexual functioning was assessed by the Female Sexual
Function Index (FSFI; Rosen et al. 2000; Ter Kuile et al. 2006). Questions from debriefing, scales: prior
experience vibrostimulation 1 (never)–5 (very often); pleasantness US 1 (not pleasant at all)–5 (very pleasant);
US perceived as sexually arousing 1 (not sexually arousing at all)–5 (very sexually arousing); declared sexual
arousal 1 (not sexually aroused at all)–5 (very sexually aroused)
*p< 0.05
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p=0.29. On TIR, there was a trend for a stimulus × condition
interaction, F(1, 54) =3.16, p=0.08, ηp
2=.06, and for a stimu-
lus × trial × condition interaction, F(5, 250)=2.19, p=0.06,
ηp
2=.04. Inspection of Fig. 2 suggests that the placebo condi-
tion demonstrated greater differential responding in the sec-
ond half of the acquisition phase compared to the haloperidol
condition. Additional analysis of the first half of the acquisi-
tion trials (trials 1–4 of acquisition phase) yielded a significant
stimulus × trial × condition interaction effect on TIR F(3,
143)=3.87, p<0.02, ηp
2=.07, and analysis of the second half
of the acquisition phase (trials 5–8) yielded a significant stim-
ulus × condition interaction on TIR, F(1, 55)=4.65, p<0.04,
ηp
2=.08. Because conditions differed in age, with the placebo
condition being significantly older than the haloperidol con-
dition (see Table 1), and in prior experience with
vibrostimulation and in the difference in VPA towards CS+/
CS− during the preconditioning phase, additional analyses
were conducted with those variables as covariates. On TIR,
again a significant main effect of stimulus was seen, F(1,
51)=5.23, p<0.03, ηp
2=.10, and a significant stimulus × con-
dition interaction effect, F(1, 51) = 6.32, p<0.02, ηp
2=.11.
Also, a trend for a stimulus × age interaction, p<0.09, was
seen. Concluding, the vibrostimulation resulted in a genital
arousal response in both conditions, and results from the ad-
ditional analysis showed that administration of a DA
antagonist decreased the magnitude of differential responding
towards the CS+ plus vibrostimulation and CS− in the second
half of the acquisition phase.
Extinction phase
Analysis of the first extinction trial revealed no conditioned
responding, FIR p=0.47, SIR p=0.32, TIR p=0.64, with no
differences therein between the conditions, FIR p=0.93; SIR
p = 0.99; TIR p = 0.65. The 2 (stimulus) × 6 (trial) × 2
(condition) mixed factors ANOVA of all extinction trials also
did not reveal conditioned responding, all ps>0.19, and no
stimulus × trial × condition interaction effect, all ps >0.53.
However, a less stringent method, namely analysis of only
the response towards the CS+ on the last preconditioning trial
and on the first extinction trial, revealed a difference in con-
ditioned responding between the placebo and haloperidol con-
dition, as reflected by a significant trial × condition interaction
effect on SIR, F(1, 54)=4.89, p<0.03, ηp
2=.08, and a trend for
a trial × condition interaction on TIR F(1, 54)=3.81, p<0.06,
ηp
2=.07. Additional analyses were conducted with the variables
age, prior experience vibrostimulation and difference in VPA
towards CS+/CS− during the preconditioning phase as covar-
iates. Analysis of the first extinction trial again revealed no
conditioned responding on FIR and SIR and no differences
Fig. 2 Mean vaginal pulse
amplitude (VPA) change scores
(with standard error bars) for the
conditions placebo and
haloperidol, during the third
interval response window (TIR)
following CS+ and CS− during
the preconditioning phase,
acquisition phase and extinction
phase. Note that during the
acquisition phase, the response
represents responding to the CS+
plus the US (given that animal
studies on conditioned sexual
response have revealed
interactions between sex steroids
and DA in the control of sexual
behaviour (see Brom et al. 2014a)
and have revealed influences of
estrous cycle phase on
conditioning and extinction
(Milad et al. 2006); additional
analyses were conducted,
controlled for women during their
early follicular phase (i.e. early
cycle) and during the late
follicular phase (i.e. midcycle).
However, those analyses revealed
no additional differences between
conditions
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therein between conditions, all ps >0.28. On TIR, a trend of
stimulus was seen, F(1, 49)=3.51, p<0.07, ηp
2=.07, but a non-
significant stimulus × condition interaction effect, p=0.11.
Additionally, the 2 (stimulus) × 6 (trial) × 2 (condition) mixed
factors ANOVA of all extinction trials now revealed condi-
tioned responding on SIR, F(1, 49)=5.25, p<0.03, ηp
2=.10,
but no differences therein between conditions, p=0.23. On
TIR, no conditioned responding was seen, again with no dif-
ferences therein between conditions, all ps >0.10. The analy-
sis of only responses towards the CS+ on the last precondi-
tioning trial and on the first extinction trial revealed no differ-
ence in conditioned responding between the conditions, all
ps >0.10. To conclude, administration of haloperidol did not
decrease the magnitude of the conditioned sexual response
compared to the placebo condition.
Subjective measures
Preconditioning phase
The 2 (stimulus) × 4 (trial) × 2 (condition) mixed factors
ANOVA to verify equal levels of responding to the CSs re-
vealed no difference in responding following presentation of
the CS+ and CS− on affective value and subjective sexual
arousal, or between conditions, all ps >0.25.
Extinction phase
Subjective affect
As can be seen in Fig. 3, contrary to the expectations, for
subjective affect, there was no robust increase of differential
responding towards CS+ and CS− after the acquisition phase.
Analysis of the first extinction trial revealed no significant
stimulus × condition interaction effect, p=0.98, and no main
effect of stimulus, p=0.14. Analysis of ratings of affective
value during the preconditioning phase (mean trials 1–4) and
the first extinction trial revealed no stimulus × condition in-
teraction effect, p=0.83, nor a stimulus × trial × condition
interaction effect, p=0.70. The 2 (stimulus) × 6 (trial) × 2
(condition) mixed factors ANOVA of all extinction trials re-
vealed no differences between conditions, as reflected by non-
significant stimulus × condition and stimulus × trial × condi-
tion interaction effects, all ps >0.64. A trend of stimulus was
seen, F(1, 48) =2.97, p=0.09, ηp
2=.06. Analysis with age and
prior experience vibrostimulation as covariates showed a sim-
ilar pattern of results.
Subjective sexual arousal
Figure 4 shows increased ratings of subjective sexual arousal
towards the CS+ on the first trials of the extinction phase,
indicating conditioned response, in both conditions. Analysis
of ratings of subjective sexual arousal during the precondition-
ing phase (mean trials 1–4) and the first extinction trial re-
vealed no significant stimulus × condition interaction effect,
p=0.48, or stimulus × trial × condition interaction effect,
p=0.91. However, a significant main effect of stimulus was
seen, F(1, 54)=9.71, p<0.01, ηp
2=.15, indicating conditioned
responding. Analysis of the first extinction trial yielded no
significant stimulus × condition interaction, p=0.76. Again,
a main effect of stimulus was found, F(1, 55) =7.06, p=0.01,
ηp
2=.11. The 2 (stimulus) × 6 (trial) × 2 (condition) mixed
factors ANOVA of all extinction trials revealed no significant
interaction effects of stimulus × condition or stimulus × trial ×
condition, both ps >0.39. However, there was a significant
stimulus × trial interaction effect, F(3, 148)=2.76, p=0.04,
ηp
2=.06, indicating extinction of conditioned responding.
Analyses with age and prior experience vibrostimulation as
covariates showed a similar pattern as reported above. To
conclude, the modulation of dopaminergic tone with haloper-
idol did not decrease the magnitude of conditioned subjective
affect or sexual arousal as compared to the placebo condition.
Magnitude of the conditioned genital response
Compared to the unconditioned genital response, the magni-
tude of the CR during the first extinction trial was 116.8 and
Fig. 3 Subjective affect ratings (with standard error bars) following the CS+ and CS− during the preconditioning phase and extinction phase in the two
conditions placebo (left) and haloperidol (right)
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98 %, respectively, for VPA SIR and TIR for the placebo
condition. For the DA condition, this was 72.2 and 51.1 %.
No significant differences were seen between conditions
therein, all ps>0.28.
Conclusions
To investigate whether DA signalling is a prerequisite in sex-
ual reward learning in humans, dopaminergic tone in healthy
women during a sexual conditioning paradigm was manipu-
lated. First, results demonstrated that DA receptor antagonism
reduced sexual stimulation-induced genital sexual arousal,
emphasizing the importance of DA in unconditional
responding to sexual stimulation. However, contrary to the
expectations, no differences in conditioned genital responding
were seen between the placebo and haloperidol condition after
the acquisition phase. Both conditions demonstrated only
slight conditioned genital response, but only after correcting
for age, prior experience with vibrostimulation and for the
difference in genital response towards the CSs during the pre-
conditioning phase. Regarding ratings of affective value,
contrary to the expectations, no differential responding
towards CS+ and CS− after the acquisition phase could
be detected, and contrary to the hypothesis, no differ-
ences therein were seen between conditions. For ratings
of subjective sexual arousal, women in both the placebo
and haloperidol condition demonstrated increased ratings
towards the CS+ on the first trials of the extinction
phase. However, the conditions did not differ in this conditioned
response.
Results from the present study suggest that DA availability
indeed contributes to unconditioned behavioural responses to
sexual rewarding stimuli. This is in accordance with previous
work that showed that DA systems are involved in (sexual)
reward signalling (Both et al. 2005; Brom et al. 2014a;
Georgiadis and Kringelbach 2012; Oei et al. 2012). Quite
intriguing is the finding that DA downregulation did not seem
to affect subsequent conditioned genital response and
conditioned subjective sexual arousal. However, it is impor-
tant to keep in mind that only very weak conditioned genital
responding was seen, making it not straightforward to con-
clude that administration of the DA receptor antagonist halo-
peridol did not influence conditioned sexual response in
healthy women. This is also evidenced by the data on the
magnitude of the genital conditioned response. This finding
of only mild conditioned genital response is surprising, espe-
cially when considering that similar parameters to those of
previous research were used, when evidence for genital con-
ditioning effects were found (Both et al. 2008, 2011; Brom
et al. 2014b, c). Compared to this previous research, in the
present study, women in both conditions rated the US as less
pleasant and less sexually arousing. Although we do not have
a clear explanation for why women experienced the US as less
sexually arousing and why no conditioned genital response
could be detected in the placebo condition, we shouldmention
that sexually conditioned genital responses have generally
been found to be small (Brom et al. 2014a; Hoffmann et al.
2004; O’Donohue and Plaud 1994). Of importance, women in
the placebo condition had significantly more experience with
genital vibrostimulation. Since the attribution of incentive sa-
lience is the product of previous experience (i.e. learned asso-
ciations; habituation) interacting with someone’s genetic pro-
pensity and neurobiological state (Flagel et al. 2011), it could
be that the US was less effective and rewarding for partici-
pants in the placebo condition. The above makes clear that
further replications of the sexual conditioning results in inde-
pendent samples are highly important.
Although administration of haloperidol resulted in an at-
tenuated unconditioned genital response, this did not seem to
affect the perceived pleasantness or sexual arousability of the
US or the magnitude of conditioned subjective sexual arousal.
Moreover, in an earlier study on sexual response (Both et al.
2005), levodopa seemed only to increase T reflex magnitude
in response to sexual stimulation in men (and not in women),
whereas genital and subjective sexual arousal were not affect-
ed by levodopa. This suggests that subjectively reported feel-
ings may not be affected by DA signalling. The conscious
Fig. 4 Ratings (with standard error bars) of subjective sexual arousal following the CS+ and CS− during the preconditioning phase and extinction phase
in the two conditions placebo (left) and haloperidol (right)
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awareness of a motivational state may be dissociable from the
underlying motivational processes (Berridge 1996; Berridge
and Kringelbach 2008). Moreover, the fact that sexual re-
sponse systems can diverge has long been recognized, espe-
cially in women (Chivers et al. 2010; Laan and Everaerd
1995; Laan et al. 1995). Women can show increases in VPA,
while no increases in self-reported sexual arousal are ob-
served, or vice versa.
Several limitations of the current study should be not-
ed. Although we may assume that the administration of
3 mg haloperidol 3 h before the start of the experimental
procedure indeed effectively inhibited dopaminergic tone
(Darby et al. 1995; Liem-Moolenaar et al. 2010;
Nordstrom et al. 1992; Oei et al. 2012), also reflected
by the difference in reported adverse effects between the
haloperidol and placebo conditions, future studies should
incorporate additional sensitive measurements of drug-
induced CNS effects (Liem-Moolenaar et al. 2010), to
assure testing during maximal plasma concentrations.
Moreover, since haloperidol exhibits polypharmacology
(i.e. it may affect multiple receptor proteins in the nervous
system; Seeman 2002; Videbaeck et al. 2001), future stud-
ies on sexual reward learning in humans should preferably
make use of positron emission tomography and selective
ligands in order to be able to attribute its effects to action
on D2 receptors. Second, the present study sample
exclusively comprised women. Results from a fMRI
study by Klucken et al. (2009) on sexual conditioning
revealed stronger conditioned activation in the amygdala,
thalamus and occipital cortex in men compared to women.
The researchers considered these results to be in line with
other findings (Gutiérrez and Domjan 1997; Pfaus et al.
2001). Research has demonstrated that gender differences
in the number of DA neurons are influenced by several
factors , including sex chromosome complement
(Lombardo et al. 2012), the presence of the SRY gene
(Dewing et al. 2006) and gonadal hormones. Moreover,
it is suggested that testosterone regulates incentive sensi-
tivity through interactions with mesolimbic DA pathways
(Hermans et al. 2010; Wood 2008). Additionally, previous
studies have reported conflicting results about the effects
of DA on female sexual motivation in animals and
humans (Both et al. 2005). This and present findings
make clear that future research on the role of DA in sex-
ual learning in both sexes in humans is warranted, as
these findings may help in the understanding of the bio-
logical mechanisms underpinning addictive behaviours
and how these may affect vulnerability to drug abuse or
the development of sexual dysfunctions in men and wom-
en. In the present study, almost all participants used hor-
monal contraception. It is known that hormonal contra-
ception may have an influence on the neurochemical reg-
ulation of dopaminergic midbrain areas involved in
neurobiological processes, herewith affecting reward
learning (Brom et al. 2014a; Pletzer and Kerschbaum
2014; Sotomayor-Zarate et al. 2014). Therefore, future
studies on sexual reward learning in women should pref-
erably include a larger sample of women, in order to in-
vestigate the influence of hormonal contraceptives on sex-
ual reward learning. Additionally, in the present study,
vaginal photoplethysmography was used as indicator of phys-
iological sexual arousal. Vaginal engorgement, however, is
only one of many co-occurring processes during the sexual
arousal response. Functional imaging studies on the role of
DA in sexual reward learning in healthy men and women
may provide complementary insight in neurochemical
mechanisms involved in sexual behaviours, which may
help foster potentially critical insights in the aetiology of
disorders in sexual motivation. Since sexual arousal can
eventually result in overt behaviour such as approach and
consumption (Dekker and Everaerd 1989), future studies
should also incorporate a behavioural task to assess auto-
matic action tendencies (Brom et al. 2014b; Wiers et al.
2011). Lastly, another limitation of the present study is the
absence of a between-subjects (unpaired) control group.
Such a control group would help to distinguish learning
about the CS+ and the CS− (Domjan 2010; Hoffmann
et al. 2014). Therefore, making use of such a control
group in future research is desirable.
In conclusion, the current study is the first that investigated
the role of DA in human sexual reward learning. The present
results do not indicate an effect of DA antagonism on condi-
tioned sexual response in women. However, effects of
inhibiting dopaminergic tone with a DA antagonist
(haloperidol) were seen in the magnitude of unconditional
genital responding to sexual stimulation. Future studies on
the role of DA in human sexual reward learning are warranted,
while facilitation as well as impairment of sexual reward
learning is relevant in the context of treatment of hyposexual
and hypersexual desire disorder.
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